(Philadelphia,
PA) - Stefania Gallucci, MD, has been appointed
Assistant Professor in the Department of Pediatrics
at the University of Pennsylvania School of Medicine.
Dr. Gallucci's research focuses on the initiation and
regulation of the immune response. Her laboratory specifically
studies dendritic cells (DCs), the most important antigen-presenting
cells that are in charge of stimulating an immune response.
Together with her colleagues, she is investigating the
function and life span of DCs, depending on their state
of activation, the type of immune response they elicit
and the inflammatory environment surrounding them. Her
lab is also interested in understanding the role of
DCs in the autoimmune disorder systemic lupus erythematosus.
Dr. Gallucci hopes to discover new ways to prolong the
function of DCs to improve DC-based and other innovative
vaccines needed to fight tumors and infectious diseases.
Her work has been published in numerous journals including
Autoimmunity, Clinical Experimental Immunology
and Nature Medicine.
Dr. Gallucci, a native of Italy, earned her MD (magna
cum laude) from Catholic University of Sacred Heart
Medical School in Rome, Italy. She performed her residency
in Clinical Pathology there also. Her Fellowship in
Immunology was completed in the Laboratory of Cellular
and Molecular Immunology at the National Institute of
Allergy and Infectious Diseases, part of the National
Institutes of Health.
She is a member of the American Association of Immunologists
and was last invited to lecture at the conference, 'Keystone
Symposium on Dendritic Cells: Interfaces with Immunobiology
and Medicine' in New Mexico.
# # #
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.